Recombinant IL-1RN protein from horse (equine), expressed in Escherichia coli and supplied lyophilized with an N-terminal 6xHis tag. Intended for research on IL-1 signaling and inflammation, the product has a predicted molecular mass of ~17.2 kDa and a purity greater than 95% by reducing SDS-PAGE. Reconstitution guidance advises concentrations ≥100 μg/mL; store lyophilized at -20°C and freeze aliquots at -20°C or -80°C for extended storage.
- Recombinant equine interleukin-1 receptor antagonist with N-terminal 6xHis tag.
- Expressed in Escherichia coli.
- Predicted molecular mass ~17.2 kDa (≈18 kDa by SDS-PAGE).
- Purity greater than 95% as determined by reducing SDS-PAGE.
- Lyophilized formulation from 50 mM Tris-HCl, 300 mM NaCl, pH 7.4.
- Reconstitution recommended at concentrations ≥100 μg/mL.
- Store lyophilized at -20°C; aliquot and freeze at -20°C or -80°C for long term.